Article
Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.
Protein engineering, design & selection : PEDS - 1 Apr 2017
Yachnin Brahm J, Khare Sagar D
Abstract excerpt
Carboxypeptidase G2 (CPG2) is an Food and Drug Administration (FDA)-approved enzyme drug used to treat methotrexate (MTX) toxicity in cancer patients receiving MTX treatment. It has also been used in directed enzyme-prodrug chemotherapy, but this strategy has been hampered by off-site activation of the prodrug by the circulating enzyme. The development of a tumor protease activatable CPG2, which could be achieved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
